Skip to main content
BDXBecton, Dickinson and CompanyHold5.6·$155.92+3.00%
BDX · Concentration risk · 10-K extracted

Becton, Dickinson and (BDX) concentration risks

Updated

The most significant concentration Becton, Dickinson and discloses is sole sourced, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Becton, Dickinson and’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH1
MEDIUM1
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partySupplier

sole sourced

10-K Item 1: 'there are situations where raw materials and components may only be obtained from one supplier, which are referred to as sole sourced'
SEC 10-K · filed Nov 2025
MEDIUMBuilt-inGeographic

international operations

10-K Item 1A: 'A substantial amount of our sales come from our operations outside the U.S.'
SEC 10-K · filed Nov 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's disclosed concentration profile spans two dimensions — supply chain and geographic reach — that reflect the inherent complexity of a large, globally distributed medical technology manufacturer. On the supply side, there are situations where raw materials and components may only be obtained from one supplier — a high-share structural exposure by disclosed size. Sole-sourced inputs in a regulated device manufacturing context carry elevated risk because regulatory-approval requirements for alternate sourcing can extend substitution timelines well beyond what commodity manufacturers face; a sole-source disruption therefore has a longer tail than a standard supply-chain interruption. The geographic exposure is medium-share and structural: a substantial amount of sales come from operations outside the U.S., with international operations spanning multiple regions. This reflects deliberate global market positioning rather than reliance on any single country. Currency translation, country-specific regulatory requirements, and geopolitical trade conditions are the principal channels through which international concentration affects results. Taken together, the two exposures sit on opposite ends of the idiosyncratic-versus-structural spectrum. The sole-sourced component risk is the more actionable of the two because disruptions there are specific and can occur without macro warning. The international revenue exposure is diffuse and moves with broad macro and foreign-exchange cycles. Investors should track the depth of sole-sourcing in the manufacturing base and whether the company is actively qualifying alternate suppliers as a mitigation against that high-share dependency.

For the engine’s reasoning on BDX’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Instruments & Supplies

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
BLCOBausch + Lomb Corporation2002
BAXBaxter International Inc.1203
ATRAptarGroup, Inc.1102
BDXBecton, Dickinson and Company1102
ALGNAlign Technology, Inc.1001
AVTRAvantor, Inc.1001

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks BDX Concentration risk